National Brain Tumor Society Funding and Support of Innovative Research Helps Bring About an Immunotherapy Clinical Trial With Encouraging Results
Today, encouraging results from a small, early-stage clinical trial for glioblastoma patients were reported in the scientific and medical journal, Clinical Cancer Research. The phase one study of 11 newly diagnosed glioblastoma (GBM) patients showed that combining an experimental immunotherapy with chemotherapy (temozolomide), along with an injection to prime the immune system, was well tolerated […]
April 14, 2017